Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

Clinical trial NCT05586971 · COMPLETED

Trial details

NCT number: NCT05586971
Sponsor: LG Chem
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gout Hyperuricemia Gout Flare Tophi

Start date: 2023-03-30
Primary completion: 2025-05-06
Enrollment: 2202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.